skip to content »


Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Dennis R. Mosier, M.D., Ph.D.

Dr. Dennis R. Mosier


Dennis R. Mosier, M.D., Ph.D.

Associate Professor of Neurology

Clinical Service Area



Muscular Dystrophy
General Neurology

Board Certification

American Board of Psychiatry and Neurology, Neurology

Clinic Appointments




Medical School

M.D./Ph.D., University of Florida College of Medicine, Gainesville, Fla.


Internal Medicine, Baylor College of Medicine, Houston, Texas


Neurology, Baylor College of Medicine, Houston, Texas

Clinic Location

Baylor Neurology
Smith Tower
6550 Fannin, Suite 1801
Houston, Texas 77030

Clinical Interests

Neuromuscular disorders such as amyotrophic lateral sclerosis (Lou Gehrig's disase), myasthenia gravis, and muscle diseases, neurodegenerative diseases

Contact Information

Dennis R. Mosier, M.D., Ph.D.
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Tel: 713-798-4227
Fax: 713-798-3091

Journal Publications (Selected out of 26)

  • Oshima M, Deitiker PR, Glenn Smith R, Mosier D, Zouhair Atassi M. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients. Autoimmunity. 2012;45(2):153-60. [View journal article]
  • Deitiker PR, Oshima M, Smith RG, Mosier D, Atassi MZ. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. Int J Immunogenet. 2011;38(1):55-62. [View journal article]
  • Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, Cooper TA. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A. 2008;105(7):2646-51. [View journal article]
  • Kawai M, Gundogdu B, Kwan J, Mosier DR. Inflammatory cells invading non-necrotic muscle fibers in myotonic dystrophy type 2. J Clin Neuromuscular Dis. 2007;8:212-6. [View journal article]
  • Deitiker PR, Oshima M, Smith RG, Mosier DR, Atassi MZ. Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 2006;39(4):277-88. [View journal article]
  • Jha S, Xu K, Maruta T, Oshima M, Mosier DR, Atassi MZ, et al. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J Neuroimmunol. 2006;175(1-2):107-17. [View journal article]
  • Oshima M, Maruta T, Ohtani M, Deitiker PR, Mosier D, Atassi MZ. Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. J Neuroimmunol. 2006;171(1-2):8-16. [View journal article]
  • Oshima M, Deitiker PR, Mosier DR, Smith RG, Atassi MZ. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity. Hum Immunol. 2005;66(1):32-42. [View journal article]
  • Oshima M, Ohtani M, Deitiker PR, Smith RG, Mosier DR, Atassi MZ. Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients. Autoimmunity. 2005;38(2):161-9. [View journal article]
  • Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci. 2005;25(5):1219-25. [View journal article]

Poster and Platform Presentations

  • Shanina E, Mosier D, Smith RG. Motor neuropathy in Fascioscapulohumeral Dystrophy (FSHD). Ann Neurol. 2009;66 Suppl 1:S23.
  • Mosier D, Smith R. Searching for unicorns: The neurologist as diagnostician for rare disorders. Neurology. 2009;72(11 Suppl 3):A209.
  • Nord K, Mosier D. Myasthenia mimics. J Clin Neuromuscular Disease. 2009;10:156.

E-mail this page to a friend